Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Crowdfunded Digital Health Investment Fund Launches

An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies. . . . → Read More: Crowdfunded Digital Health Investment Fund Launches

Teva Licenses Pain Relief Antibody for $1.25 Billion

Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion

Stem Cell Treatments Show Benefit for ALS Patients

A clinical trial testing the safety of treatments derived from patients’ stem cells shows patients with ALS were able to slow the progression of their disease. . . . → Read More: Stem Cell Treatments Show Benefit for ALS Patients

Antibody Treatment Shown to Prevent Migraine

(geralt, Pixabay)

9 June 2016. A clinical trial shows an engineered antibody in one week reduced the number of headaches in people who experienced migraines for an average of 18 years. Results of the study testing the experimental treatment appear in yesterday’s issue of the journal Neurology, published by American Academy of Neurology.

Migraine . . . → Read More: Antibody Treatment Shown to Prevent Migraine

Venture Firm Funding Univ. Blood Diagnostics Technology

(Public Domain Pictures/Pixabay)

23 May 2016. A life sciences venture capital company is funding development of a technology at an Israeli research lab using DNA from blood tests to diagnose a range of diseases. Aurum Ventures is providing $1.2 million to Hebrew University of Jerusalem, through its technology transfer affiliate Yissum Research Development Company, . . . → Read More: Venture Firm Funding Univ. Blood Diagnostics Technology

ReWalk, Wyss Institute Developing Soft Exoskeleton Robot

Robotic exosuit being tested (Biodesign Lab, Harvard University)

17 May 2016. A robotics company is licensing technology from a bioengineering lab at Harvard University to develop systems for people needing help with mobility, such as those with multiple sclerosis or suffering a stroke. Financial aspects of the deal between ReWalk Robotics Ltd. in Yokneam . . . → Read More: ReWalk, Wyss Institute Developing Soft Exoskeleton Robot

Students Design Pad to Collect Urinary Infection Samples

UCap microfiber pad (Hebrew University of Jerusalem)

14 January 2016. A team at Hebrew University in Jerusalem designed a microfiber pad to improve collection of urine samples from people with urinary tract infections. Graduate students from a number of disciplines developed the pad under in the Israeli university’s Biodesign medical innovation program.

Infections can . . . → Read More: Students Design Pad to Collect Urinary Infection Samples

Trials Show Safety, Benefit of Stem Cells to Treat ALS

(AllanAjifo, Wikimedia Commons)

11 January 2016. Two clinical trials testing stem cells to treat amyotrophic lateral sclerosis, or ALS, found the treatments are safe for patients, and can slow progression of the disease. Results of the trials testing the stem cell product known as NurOwn made by BrainStorm Cell Therapeutics in Petach Tikvah, Israel . . . → Read More: Trials Show Safety, Benefit of Stem Cells to Treat ALS

Trial Underway Testing Flesh-Eating Bacteria Drug

Streptococcus pyogenes bacteria (Centers for Disease Control and Prevention)

7 December 2015. A late-stage clinical trial began enrolling patients to test a new treatment for rare, but dangerous bacterial infections that destroy soft tissue and muscle. The trial is testing AB103, a biologic therapy developed by the biotechnology company Atox Bio in Ness Ziona, . . . → Read More: Trial Underway Testing Flesh-Eating Bacteria Drug

Winners of ALS Variation Models Challenge Announced

Physicist Stephen Hawking in 2013 with David Fleming, manager of the Intel Innovation Open Lab in Ireland, center, and Martin Curley, vice president of Intel Labs Europe (Intel Free Press/Flickr)

5 November 2015. Participants from universities in the U.S. and Taiwan are winners of a challenge to develop mathematical models that predict variations in . . . → Read More: Winners of ALS Variation Models Challenge Announced